NCT00376688View on ClinicalTrials.gov

Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

July 11, 2006

Primary Completion Date

June 12, 2008

Study Completion Date

December 16, 2019

Conditions
Recurrent Breast CarcinomaStage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7Stage IIIB Breast Cancer AJCC v7Stage IIIC Breast Cancer AJCC v7Stage IV Breast Cancer AJCC v6 and v7
Interventions
OTHER

Laboratory Biomarker Analysis

Correlative studies

DRUG

Temsirolimus

Given IV

Trial Locations (2)

60637

University of Chicago Comprehensive Cancer Center, Chicago

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00376688 - Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter